FFA
IMGN

Founders Financial Alliance’s Immunogen Inc IMGN Stock Holding History

Founders Financial Alliance’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-23
Closed – – 1313
2020
Q3 		$0 Buy
+23
New +$93 ﹤0.01% 1413

Other funds holding IMGN

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Founders Financial Alliance's IMGN Position: Q4 2020 in Review

Founders Financial Alliance sold out of Immunogen Inc (IMGN) in Q4 2020, closing a stake of 23 shares.

Founders Financial Alliance first reported a position in IMGN in Q3 2020 and held it in 1 quarter. The position peaked at $0 in Q3 2020. 211 funds tracked by Wall St. Rank hold IMGN as of Q4 2020.

  • Founders Financial Alliance reported no remaining Immunogen Inc position as of Q4 2020 after selling out during the quarter.
  • Founders Financial Alliance sold 23 Immunogen Inc shares in Q4 2020.
  • Founders Financial Alliance first reported a position in Immunogen Inc in Q3 2020 and held it in 1 quarter.
  • Founders Financial Alliance's Immunogen Inc position peaked at $0 in Q3 2020.
  • 211 funds tracked by Wall St. Rank held Immunogen Inc as of Q4 2020.

Based on Founders Financial Alliance's 13F filing for Q4 2020, filed 4 Feb 2021.